Testing a smaller treatment edge in radiosurgery for tumors that spread to the brain
Official title: Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This trial is comparing two sizes of the treated area around a brain tumor during focused radiation.
Read our full plain-language summary
What the trial team says
Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.
Key facts
- Registry number
- NCT06857006
- Stage of testing
- Not applicable
- Conditions studied
- Brain Metastases
Where it is running
This trial lists 1 site.
-
Alabama
- University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center (Birmingham)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.